Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net loss	$ (8,717,142)	$ (8,421,892)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	0	48,202
Stock-based compensation expense	556,261	478,560
Amortization of premium and discount on marketable securities	(45,439)	0
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	(118,025)	(291,068)
Accounts payable, accrued expenses and other liabilities	(412,662)	(317,576)
Net cash used in operating activities	(8,737,007)	(8,503,774)
Cash flows provided by investing activities:
Purchase of marketable securities	(31,615,825)	0
Maturities of marketable securities	9,000,000	0
Net cash used in investing activities	(22,615,825)	0
Proceeds from the sale of preferred stock	5,000	0
Proceeds from the exercise of common stock warrants	0	2,201,450
Proceeds from the sale of common stock	0	31,094,302
Net cash provided by financing activities	5,000	33,295,752
Net (decrease) increase in cash and cash equivalents	(31,347,832)	24,791,978
Cash and cash equivalents at beginning of period	37,313,558	18,515,595
Cash and cash equivalents at end of period	5,965,726	43,307,573
Supplemental disclosure of non-cash activities:
Unrealized loss on marketable securities	$ 86,583	$ 0